Published in Expert Opin Ther Targets on February 01, 2004
Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther (2007) 2.62
Impact of RNA editing on functions of the serotonin 2C receptor in vivo. Front Neurosci (2010) 1.01
Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex. J Neurochem (2010) 0.98
5-HT2C receptors in the basolateral amygdala and dorsal striatum are a novel target for the anxiolytic and antidepressant effects of exercise. PLoS One (2012) 0.86
Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex. Neuroscience (2015) 0.84
Serotonin 2c receptor RNA editing in major depression and suicide. World J Biol Psychiatry (2012) 0.84
Effects of the 5HT2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behavior. Psychopharmacology (Berl) (2012) 0.79
Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats. Psychopharmacology (Berl) (2007) 0.79
Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity. Exp Brain Res (2014) 0.76
The epidemiology of the dementias: an update. Curr Opin Psychiatry (2007) 2.05
Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc (2007) 1.65
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. J Clin Psychopharmacol (2005) 1.41
Serotonin transporter gene variants and behavior: a comprehensive review. Curr Drug Targets (2006) 1.29
The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. Int J Neuropsychopharmacol (2004) 1.29
New antipsychotics and schizophrenia: a review on efficacy and side effects. Curr Med Chem (2004) 1.22
HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Curr Med Chem (2007) 1.11
Increased recognition of depression in primary care. Comparison between primary-care physician and ICD-10 diagnosis of depression. Psychother Psychosom (2005) 1.07
Pet therapy in elderly patients with mental illness. Psychogeriatrics (2010) 1.05
The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. Int J Eat Disord (2011) 1.05
Depressive symptomatology is influenced by chronotypes. J Affect Disord (2009) 1.02
Differential item functioning related to education and age in the Italian version of the Mini-mental State Examination. Int Psychogeriatr (2006) 0.98
Genetics of Alzheimer's disease. A rapidly evolving field. J Alzheimers Dis (2007) 0.97
Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways. Int J Alzheimers Dis (2011) 0.97
Depression and frequent attendance in elderly primary care patients. Gen Hosp Psychiatry (2006) 0.97
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry (2014) 0.96
Vision and hearing impairments are associated with depressive--anxiety syndrome in Italian elderly. Aging Ment Health (2011) 0.94
Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology (2011) 0.93
Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. J Psychiatr Res (2010) 0.93
Cognitive impairment after age 60: clinical and social correlates in the Faenza Project. J Alzheimers Dis (2010) 0.92
Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia. Neurosci Res (2005) 0.92
Pharmacogenetics in the treatment of depression: pharmacodynamic studies. Pharmacogenet Genomics (2005) 0.91
Pharmacogenetics of antidepressant response: an update. Hum Genomics (2009) 0.89
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? Eur Neuropsychopharmacol (2010) 0.87
Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. Biomed Pharmacother (2008) 0.86
Immediate versus gradual suspension of previous treatments during switch to aripiprazole: results of a randomized, open label study. Eur Neuropsychopharmacol (2009) 0.86
Correlation of a set of gene variants, life events and personality features on adult ADHD severity. J Psychiatr Res (2009) 0.86
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.86
From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes. Psychopharmacology (Berl) (2004) 0.85
Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants. Psychiatr Genet (2006) 0.85
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients. Int Clin Psychopharmacol (2009) 0.84
Clinical risk factors for neuroleptic malignant syndrome. Hum Psychopharmacol (2002) 0.84
Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2012) 0.84
MAOA and MAOB polymorphisms and anger-related traits in suicidal participants and controls. Eur Arch Psychiatry Clin Neurosci (2012) 0.83
Temperament and character of suicide attempters. J Psychiatr Res (2007) 0.83
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. Int Clin Psychopharmacol (2009) 0.83
AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment. Eur Neuropsychopharmacol (2012) 0.83
HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory. Eur J Clin Pharmacol (2009) 0.83
The impact of heat shock protein 70 gene variations on clinical presentation and outcome in schizophrenic inpatients. Neuropsychobiology (2009) 0.83
Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol. Eur Arch Psychiatry Clin Neurosci (2012) 0.82
Occurrence of cognitive impairment after age 90: MCI and other broadly used concepts. Brain Res Bull (2005) 0.82
Pharmacogenetics of antidepressants. Front Pharmacol (2011) 0.82
Different classification systems yield different dementia occurrence among nonagenarians and centenarians. Dement Geriatr Cogn Disord (2003) 0.82
Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder. Psychopharmacology (Berl) (2004) 0.82
Dysbindin gene (DTNBP1) and schizophrenia in Korean population. Eur Arch Psychiatry Clin Neurosci (2009) 0.82
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients. J Affect Disord (2009) 0.82
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders. World J Biol Psychiatry (2011) 0.81
Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder. Psychiatry Res (2012) 0.81
Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up. Pharmacogenetics (2004) 0.81
COMT and age at onset in mood disorders: a replication and extension study. Neurosci Lett (2011) 0.81
Genes involved in Alzheimer's disease, a survey of possible candidates. J Alzheimers Dis (2005) 0.81
Quetiapine for bipolar depression: a systematic review and meta-analysis. Int Clin Psychopharmacol (2012) 0.81
Late-life depression in primary care: a nationwide Italian epidemiological survey. J Am Geriatr Soc (2002) 0.81
Serotonin transporter gene and adverse life events in adult ADHD. Am J Med Genet B Neuropsychiatr Genet (2008) 0.81
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression. Neuropsychobiology (2012) 0.81
Tachykinin receptor 1 variants associated with aggression in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet (2007) 0.81
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. J Affect Disord (2011) 0.81
Novel antidepressants and panic disorder: evidence beyond current guidelines. Neuropsychobiology (2010) 0.81
Antidepressant response in the elderly. Psychiatry Res (2007) 0.80
Generalized tonic-clonic seizure secondary to duloxetine poisoning: a short report with favorable out come. Neurotoxicology (2012) 0.80
Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.80
Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression. J Clin Psychopharmacol (2003) 0.80
Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy. Pharmacogenet Genomics (2007) 0.80
Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta). Curr Med Chem (2009) 0.80
APOE epsilon-4 allele and cytokine production in Alzheimer's disease. Int J Geriatr Psychiatry (2010) 0.80
Heat-shock protein-70 genes and response to antidepressants in major depression. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.80
Prevalence and characteristics of mild cognitive impairment in the general population. Data from an Italian population-based study: The Faenza Project. Aging Ment Health (2012) 0.80
Lack of association between interleukin-1 alpha rs1800587 polymorphism and Alzheimer's disease in two Independent European samples. J Alzheimers Dis (2009) 0.79
Depression and social phobia secondary to alcohol dependence. Neuropsychobiology (2008) 0.79
No influence of FAT polymorphisms in response to aripiprazole. J Hum Genet (2009) 0.79
Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism. Expert Opin Drug Metab Toxicol (2011) 0.79
Predicting response to lithium in mood disorders: role of genetic polymorphisms. Am J Pharmacogenomics (2003) 0.79
Family history of major depression and residual symptoms in responder and non-responder depressed patients. Compr Psychiatry (2013) 0.79
Genetic modulation of personality traits: a systematic review of the literature. Int Clin Psychopharmacol (2014) 0.79
Age-dependent changes in the susceptibility to apoptosis of peripheral blood CD4+ and CD8+ T lymphocytes with virgin or memory phenotype. Mech Ageing Dev (2003) 0.79
[Microsporogenesis y microgametogenesis de annatto (Bixa orellana L.)]. Acta Cient Venez (2002) 0.78
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia. Neurosci Lett (2011) 0.78
Effect of the dysbindin gene on antimanic agents in patients with bipolar I disorder. Psychiatry Investig (2008) 0.78
Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.78
Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance. J Psychopharmacol (2010) 0.78
DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients. Neurosci Lett (2008) 0.78
3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients. Chronobiol Int (2010) 0.78
Effects of SORL1 gene on Alzheimer's disease. Focus on gender, neuropsychiatric symptoms and pro-inflammatory cytokines. Curr Alzheimer Res (2013) 0.78
Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders. Am J Med Genet B Neuropsychiatr Genet (2004) 0.78
Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. J Neural Transm (Vienna) (2013) 0.78
Epistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features. Int J Environ Res Public Health (2009) 0.78
Tyrosine hydroxylase and DOPA decarboxylase gene variants in personality traits. Neuropsychobiology (2009) 0.78
Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women. Neuro Endocrinol Lett (2008) 0.78
Further evidence of MAO-A gene variants associated with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2007) 0.78
TPH2 gene variants and anxiety during alcohol detoxification outcome. Psychiatry Res (2009) 0.78
Vitamin B12 levels in Alzheimer's disease: association with clinical features and cytokine production. J Alzheimers Dis (2010) 0.78
Strategy for a genetic assessment of antipsychotic and antidepressant-related proarrhythmia. Curr Med Chem (2008) 0.77
Incomplete coverage of candidate genes: a poorly considered bias. Curr Genomics (2007) 0.77
TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: an open label study. Eur Psychiatry (2008) 0.77
No association of a set of candidate genes on haloperidol side effects. PLoS One (2012) 0.77
Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. J Affect Disord (2012) 0.77
TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. Neuropsychobiology (2012) 0.77
Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients. J Affect Disord (2013) 0.77